Global Genetic Testing Market - Industry Analysis & Market Forecast - Sales Expect to Reach $25 Billion Annually By 2021 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Genetic Testing Market - Industry Analysis And Market Forecast (2016 - 2021)" report to their offering.

Genetic Testing market sales are expected to reach $25 billion annually by 2021 with compound annual growth rate of 10% alone in United States. The Global genetic testing market is expected to reach approximately $60 billion by 2020. The US represents the largest market for genetic testing worldwide.

Genetic testing is the analysis of genes, chromosomes, or proteins to help predict the risk of disease, identify carriers (individuals who do not have the disease but have a copy of the disease gene) of disease, diagnose disease, or determine the likely course of a disease. Cytogenetics, Molecular Genetics, Cancer Genetics, Prenatal Screening and Prenatal diagnosis are type of genetic tests that involves examining a person's genetic material taken from cells in a sample of blood or, occasionally, from other body fluids or tissues.

Genetic Testing market growth is driven by increasing adoption of oncology applications, growing public awareness and demand for personalized medicine. It advances with aging population and a subsequent rise in the number of chronic diseases, and increasing incidence of cancer cases are the other factors propelling growth in the genetic testing market.

Genetic testing represents the most rapidly expanding segment of the molecular diagnostics market worldwide. Growing incidence of genetic diseases unravels new opportunities for genetic testing. The transformation of genetic testing from being a service-driven market to a product-driven market is expected to provide an impetus to the diagnostic companies for the expansion of their operations.

Companies Mentioned

  • Andme, Inc.
  • Abbott Molecular
  • Ariosa Diagnostics, Inc
  • Biocartis Sa
  • Biohelix Corporation (Wholly Owned Subsidiary Of Quidel)
  • Biomerieux S.A.
  • Celera Corporation
  • Cepheid
  • Daan Diagnostics Ltd.
  • Ekf Diagnostics Holdings Plc
  • Genentech, Inc.
  • Genomictree, Inc.
  • Others

Key Topics Covered:

1 INTRODUCTION

2 GENETIC TESTING MARKET OVERVIEW

3 GLOBAL GENETIC TESTING - MARKET FORCES

4 GLOBAL GENETIC TESTING MARKET, BY TYPES

5 GENETIC TESTING MARKET, BY GEOGRAPHY

6 COMPETITIVE LANDSCAPE

7 COMPANY PROFILES

8 DISCLAIMER

For more information about this report visit http://www.researchandmarkets.com/research/kkn54t/global_genetic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services, Genomics, Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services, Genomics, Diagnostics